Follow
Siu Kei Chow
Siu Kei Chow
Director - Infectious Diseases Diagnostics, MultiCare Health System
Verified email at uw.edu
Title
Cited by
Cited by
Year
Small intestinal bacterial overgrowth in Parkinson's disease
AH Tan, S Mahadeva, AM Thalha, PR Gibson, CK Kiew, CM Yeat, SW Ng, ...
Parkinsonism & related disorders 20 (5), 535-540, 2014
3032014
Helicobacter pylori infection is associated with worse severity of Parkinson's disease
AH Tan, S Mahadeva, C Marras, AM Thalha, CK Kiew, CM Yeat, SW Ng, ...
Parkinsonism & related disorders 21 (3), 221-225, 2015
1522015
A requirement for FcγR in antibody-mediated bacterial toxin neutralization
N Abboud, SK Chow, C Saylor, A Janda, JV Ravetch, MD Scharff, ...
Journal of Experimental Medicine 207 (11), 2395-2405, 2010
1182010
Amyloid β-peptide directly induces spontaneous calcium transients, delayed intercellular calcium waves and gliosis in rat cortical astrocytes
SK Chow, D Yu, CL MacDonald, M Buibas, GA Silva
ASN neuro 2 (1), AN20090035, 2009
972009
Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity
S Bournazos, SK Chow, N Abboud, A Casadevall, JV Ravetch
The Journal of clinical investigation 124 (2), 725-729, 2014
692014
Monoclonal antibodies and toxins—a perspective on function and isotype
SK Chow, A Casadevall
Toxins 4 (6), 430-454, 2012
662012
The effect of L-DOPA on Cryptococcus neoformans growth and gene expression
HC Eisenman, SK Chow, KK Tsé, E McClelland, A Casadevall
Virulence 2 (4), 329-336, 2011
612011
Prolonged detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in an obstetric patient with antibody seroconversion
LP Molina, SK Chow, A Nickel, JE Love
Obstetrics & Gynecology 136 (4), 838-841, 2020
602020
Cryptococcus Neoformans Galactoxylomannan is a Potent Negative Immunomodulator, Inspiring New Approaches in Anti-Inflammatory Immunotherapy
A Vecchiarelli, E Pericolini, E Gabrielli, SK Chow, F Bistoni, E Cenci, ...
Immunotherapy 3 (8), 997-1005, 2011
582011
Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans
M De Jesus, A Moraes Nicola, SK Chow, IR Lee, S Nong, CA Specht, ...
Virulence 1 (6), 500-508, 2010
522010
Evaluation of Cryptococcus neoformans galactoxylomannan–protein conjugate as vaccine candidate against murine cryptococcosis
SK Chow, A Casadevall
Vaccine 29 (10), 1891-1898, 2011
492011
Differential gene expression analysis in CCLE lesions provides new insights regarding the genetics basis of skin vs. systemic disease
R Dey-Rao, JR Smith, S Chow, AA Sinha
Genomics 104 (2), 144-155, 2014
452014
Role of CD45 signaling pathway in galactoxylomannan-induced T cell damage
E Pericolini, E Gabrielli, G Bistoni, E Cenci, S Perito, SK Chow, F Riuzzi, ...
PLoS One 5 (9), e12720, 2010
362010
Galactoxylomannans from Cryptococcus neoformans Varieties neoformans and grubii Are Structurally and Antigenically Variable
M De Jesus, SK Chow, RJB Cordero, S Frases, A Casadevall
Eukaryotic cell 9 (7), 1018-1028, 2010
342010
Fluorine-19 NMR chemical shift probes molecular binding to lipid membranes
EY Chekmenev, SK Chow, D Tofan, DP Weitekamp, BD Ross, ...
The Journal of Physical Chemistry B 112 (20), 6285-6287, 2008
332008
Identification and clinical significance of Helcococcus species, with description of Helcococcus seattlensis sp. nov. from a patient with urosepsis
SK Chow, JE Clarridge III
Journal of Clinical Microbiology 52 (3), 854-858, 2014
322014
The microbial capsular polysaccharide galactoxylomannan inhibits IL-17A production in circulating T cells from rheumatoid arthritis patients
E Pericolini, A Alunno, E Gabrielli, E Bartoloni, E Cenci, SK Chow, ...
PloS one 8 (1), e53336, 2013
252013
Combinations of monoclonal antibodies to anthrax toxin manifest new properties in neutralization assays
MA Pohl, J Rivera, A Nakouzi, SK Chow, A Casadevall
Infection and immunity 81 (6), 1880-1888, 2013
242013
Disease-enhancing antibodies improve the efficacy of bacterial toxin-neutralizing antibodies
SK Chow, C Smith, T MacCarthy, MA Pohl, A Bergman, A Casadevall
Cell host & microbe 13 (4), 417-428, 2013
242013
HTS-compatible patient-derived cell-based assay to identify small molecule modulators of aberrant splicing in myotonic dystrophy type 1
DA O’Leary, L Vargas, O Sharif, ME Garcia, YJ Sigal, SK Chow, ...
Current Chemical Genomics 4, 9, 2010
222010
The system can't perform the operation now. Try again later.
Articles 1–20